Comments on: OMRIX Biopharmaceuticals Receives FDA Approval > General Hemostasis in Surgery Indication for EVICEL(TM) Liquid Fibrin Sealant > Adjunct to hemostasis for use in patients undergoing surgery > Partners with Johnson & Johnson’s Ethicon division for biosurgical product line for hemostasis

Comments on: OMRIX Biopharmaceuticals Receives FDA Approval > General Hemostasis in Surgery Indication for EVICEL(TM) Liquid Fibrin Sealant > Adjunct to hemostasis for use in patients undergoing surgery > Partners with Johnson & Johnson’s Ethicon division for biosurgical product line for hemostasis http://www.ideasforsurgery.com/2008/01/25/omrix-biopharmaceuticals-receives-fda-approval-general-hemostasis-in-surgery-indication-for-eviceltm-liquid-fibrin-sealant-adjunct-to-hemostasis-for-use-in-patients-undergoing-surgery-partners/ Clinical Needs > Innovative Answers Fri, 30 Jul 2010 11:22:22 +0000 http://wordpress.org/?v=2.2.3